Epigenomics AG NA buy papaver
Start price
26.06.18
/
50%
€2.25
Target price
26.12.18
€3.15
Performance (%)
-16.49%
End price
26.12.18
€1.76
Summary
This prediction ended on 26.12.18 with a price of €1.76. The price of Epigenomics AG NA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.49%. papaver has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epigenomics AG NA | - | - | - | - |
| iShares Core DAX® | -2.117% | -7.974% | -1.733% | 53.340% |
| iShares Nasdaq 100 | -1.323% | -0.066% | 16.602% | 81.164% |
| iShares Nikkei 225® | -0.324% | -6.382% | 25.629% | 52.301% |
| iShares S&P 500 | -1.568% | -1.965% | 10.831% | 60.913% |
Comments by papaver for this prediction
In the thread Epigenomics AG NA diskutieren
Günstig
Vor dem Übernahmeversuch stand der Aktienkurs bei +/-- 5,00 Euro.
Inzwischen ist der Test Epicolon in Amerika eingeführt und mit einem Medikament gegen Lungenkrebs kommt die Firma gut voran.
(Laufzeit überschritten)